Mavorixafor (Xolremdi) for individuals with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Genetics in Medicine Open · 2026-06 · 104398
DOI: 10.1016/j.gimo.2026.104398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine Open, 2026-06. Verfasst von Mark Dulchavsky und 3 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dulchavsky, M., Peng, X., Hannibal, M., & Lesmana, H. (2026). Mavorixafor (Xolremdi) for individuals with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open, 104398. https://doi.org/10.1016/j.gimo.2026.104398
Vancouver
Dulchavsky M, Peng X, Hannibal M, Lesmana H. Mavorixafor (Xolremdi) for individuals with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine Open. 2026:104398. doi:10.1016/j.gimo.2026.104398
BibTeX
@article{Dulchavsky2026,
author = {Dulchavsky, Mark and Peng, Xiao and Hannibal, Mark and Lesmana, Harry},
title = {Mavorixafor (Xolremdi) for individuals with warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)},
journal = {Genetics in Medicine Open},
year = {2026},
pages = {104398},
doi = {10.1016/j.gimo.2026.104398}
}
EUVIMED